• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.05% Nasdaq Down 0.18%

    Vertex Pharmaceuticals Incorporated (VRTX)

    -NasdaqGS
    84.00 Up 3.37(4.18%) May 5, 4:00PM EDT
    Prev Close:80.63
    Open:81.41
    Bid:0.01 x 100
    Ask:N/A
    1y Target Est:110.30
    Beta:1.35675
    Earnings Date:Jul 27 - Aug 1 (Est.)
    Day's Range:80.63 - 84.07
    52wk Range:75.90 - 143.45
    Volume:1,814,625
    Avg Vol (3m):2,322,970
    Market Cap:20.77B
    P/E (ttm):N/A
    EPS (ttm):-2.31
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    VRTXUp 4.18%20.77B
    PTCTDown 1.29%235.74M
    BMYUp 0.52%118.77B
    MRKDown 1.31%149.81B

    Key Statistics

    Forward P/E (1 yr):23.80
    P/S (ttm):19.24
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :1.06
    Quarterly EPS Est (Jun-16) :0.21
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):1.55

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing medicines for serious diseases. The company focuses on developing and commercializing therapies for the treatment of cystic fibrosis (CF) an... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback